Mental Health - Costa Rica Newlook About Us - Our Services - Why Costa Rica - Contact Us - Testimonials
Mental Health - Costa Rica Newlook

TMS Treatment or Transcranial Magnetic Stimulator

The TMS or Transcranial Magnetic Stimulator device consists of a coil connected to a capacitor that generates a great electromagnetic field. As the current flows through the coil, a magnetic field up to 2 tesla is generated. The flow of this great magnetic field that has been generated alters the electrochemical functioning of neighboring brain cells through the faraday induction process.

The procedure is to place a cap, with which certain coordinates are traced to place the "8"-shaped coil on certain areas of the skull. To treat depression, the area that is stimulated is the prefrontal dorsolateral cortex, which, when stimulated, it will stimulate in turn the limbic system, an area of the brain that is essential in the genesis of depression. The coil generates a very powerful electromagnetic discharge. The discharge generates a noise of moderate intensity, so earplugs are worn. A slight tapping on the skull may also be felt. You will be awake during the procedure, and will be able to talk, read or listen to music, or to relax and sleep.

The procedure includes 2 daily sessions approximately 20 minutes each, with a 30-minute break between them. It is performed for 10 days, with a rest period of 2 days between the first 5 days and the second 5 days. There are 20 sessions in total.

The procedure has the following advantages:

1. The patient can be awake and talk with his doctor.

2. There is no need for anesthesia.

3. There are no adverse effects.

4. It is very fast, since clinical improvement is expected by the seventh day.

TMS has demonstrated its effectiveness in the following neuropsychiatric cases:

  • Treatment-resistant depression.
  • Depression in patients who cannot tolerate antidepressant drugs.
  • First choice in depression.
  • Post-partum depression.
  • Auditory hallucinations.
  • Chronic tinnitus.
  • Resistant to pharmacological treatment.
  • Chronic stroke sequelae.